Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans: an in vitro study

A. Fiore, J. M. Laparra, R. Farre, M. R. Fullone, I. Grgurina, M. Gallo, V. Fogliano*

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There are some concerns about the use of Pseudomonas-based products as biocontrol agents because of the hemolytic activity shown by their metabolites. The effects of Pseudomonas lipodepsipeptides (LDPs) on mammals via ingestion and the LDP degradation during the digestion and intestinal permeability have not been evaluated. In this research, the susceptibility of different LDPs to degradation was assayed with enzymatic gastrointestinal digestion, and intestinal permeability to LDPs was investigated in an in vitro system based on an intestinal cell layer system. Results demonstrated that trypsin and chymotrypsin hydrolyze up to 50% of the various LDPs, and that proteolysis was further increased by pronase E treatment. A decrease in LDP hemolytic activity matched LDP degradation during the various steps of the digestion process. Moreover, it was shown that syringomycin E (SRE), the main known LDP, was not able to cross the intestinal cell layer, suggesting that SRE does not reach the bloodstream in vivo. It was concluded that the Pseudomonas-based biocontrol products do not represent a serious risk for consumer health. In fact, LDPs possibly present on biocontrol-treated agricultural commodities would likely be partially digested by gastrointestinal enzymes and would not be absorbed at the intestinal level.

Original languageEnglish
Pages (from-to)979-985
Number of pages7
JournalJournal of Food Protection
Volume71
Issue number5
DOIs
Publication statusPublished - May 2008
Externally publishedYes

Cite this

Fiore, A. ; Laparra, J. M. ; Farre, R. ; Fullone, M. R. ; Grgurina, I. ; Gallo, M. ; Fogliano, V. / Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans : an in vitro study. In: Journal of Food Protection. 2008 ; Vol. 71, No. 5. pp. 979-985.
@article{2c9fc6eea9e746178c5711bb0adbb9bf,
title = "Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans: an in vitro study",
abstract = "There are some concerns about the use of Pseudomonas-based products as biocontrol agents because of the hemolytic activity shown by their metabolites. The effects of Pseudomonas lipodepsipeptides (LDPs) on mammals via ingestion and the LDP degradation during the digestion and intestinal permeability have not been evaluated. In this research, the susceptibility of different LDPs to degradation was assayed with enzymatic gastrointestinal digestion, and intestinal permeability to LDPs was investigated in an in vitro system based on an intestinal cell layer system. Results demonstrated that trypsin and chymotrypsin hydrolyze up to 50{\%} of the various LDPs, and that proteolysis was further increased by pronase E treatment. A decrease in LDP hemolytic activity matched LDP degradation during the various steps of the digestion process. Moreover, it was shown that syringomycin E (SRE), the main known LDP, was not able to cross the intestinal cell layer, suggesting that SRE does not reach the bloodstream in vivo. It was concluded that the Pseudomonas-based biocontrol products do not represent a serious risk for consumer health. In fact, LDPs possibly present on biocontrol-treated agricultural commodities would likely be partially digested by gastrointestinal enzymes and would not be absorbed at the intestinal level.",
author = "A. Fiore and Laparra, {J. M.} and R. Farre and Fullone, {M. R.} and I. Grgurina and M. Gallo and V. Fogliano",
year = "2008",
month = "5",
doi = "10.4315/0362-028X-71.5.979",
language = "English",
volume = "71",
pages = "979--985",
journal = "Journal of Food Protection",
issn = "0362-028X",
publisher = "INT ASSOC FOOD PROTECTION",
number = "5",

}

Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans : an in vitro study. / Fiore, A.; Laparra, J. M.; Farre, R.; Fullone, M. R.; Grgurina, I.; Gallo, M.; Fogliano, V.

In: Journal of Food Protection, Vol. 71, No. 5, 05.2008, p. 979-985.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans

T2 - an in vitro study

AU - Fiore, A.

AU - Laparra, J. M.

AU - Farre, R.

AU - Fullone, M. R.

AU - Grgurina, I.

AU - Gallo, M.

AU - Fogliano, V.

PY - 2008/5

Y1 - 2008/5

N2 - There are some concerns about the use of Pseudomonas-based products as biocontrol agents because of the hemolytic activity shown by their metabolites. The effects of Pseudomonas lipodepsipeptides (LDPs) on mammals via ingestion and the LDP degradation during the digestion and intestinal permeability have not been evaluated. In this research, the susceptibility of different LDPs to degradation was assayed with enzymatic gastrointestinal digestion, and intestinal permeability to LDPs was investigated in an in vitro system based on an intestinal cell layer system. Results demonstrated that trypsin and chymotrypsin hydrolyze up to 50% of the various LDPs, and that proteolysis was further increased by pronase E treatment. A decrease in LDP hemolytic activity matched LDP degradation during the various steps of the digestion process. Moreover, it was shown that syringomycin E (SRE), the main known LDP, was not able to cross the intestinal cell layer, suggesting that SRE does not reach the bloodstream in vivo. It was concluded that the Pseudomonas-based biocontrol products do not represent a serious risk for consumer health. In fact, LDPs possibly present on biocontrol-treated agricultural commodities would likely be partially digested by gastrointestinal enzymes and would not be absorbed at the intestinal level.

AB - There are some concerns about the use of Pseudomonas-based products as biocontrol agents because of the hemolytic activity shown by their metabolites. The effects of Pseudomonas lipodepsipeptides (LDPs) on mammals via ingestion and the LDP degradation during the digestion and intestinal permeability have not been evaluated. In this research, the susceptibility of different LDPs to degradation was assayed with enzymatic gastrointestinal digestion, and intestinal permeability to LDPs was investigated in an in vitro system based on an intestinal cell layer system. Results demonstrated that trypsin and chymotrypsin hydrolyze up to 50% of the various LDPs, and that proteolysis was further increased by pronase E treatment. A decrease in LDP hemolytic activity matched LDP degradation during the various steps of the digestion process. Moreover, it was shown that syringomycin E (SRE), the main known LDP, was not able to cross the intestinal cell layer, suggesting that SRE does not reach the bloodstream in vivo. It was concluded that the Pseudomonas-based biocontrol products do not represent a serious risk for consumer health. In fact, LDPs possibly present on biocontrol-treated agricultural commodities would likely be partially digested by gastrointestinal enzymes and would not be absorbed at the intestinal level.

U2 - 10.4315/0362-028X-71.5.979

DO - 10.4315/0362-028X-71.5.979

M3 - Article

VL - 71

SP - 979

EP - 985

JO - Journal of Food Protection

JF - Journal of Food Protection

SN - 0362-028X

IS - 5

ER -